Influence of CYP2C19 Genotype on the Pharmacokinetics (PK) of Voriconazole

NCT00942773 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: Voriconazole

Sponsor

Seoul National University Hospital